Edition:
United States

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

5.53USD
3:59pm EST
Change (% chg)

$0.05 (+0.91%)
Prev Close
$5.48
Open
$5.47
Day's High
$5.58
Day's Low
$5.43
Volume
178,345
Avg. Vol
265,897
52-wk High
$11.71
52-wk Low
$4.61

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Peter Crowley

59 2010 Independent Chairman of the Board

Mark Baker

62 2011 Chief Executive Officer, Director

Patrick Fabbio

49 2015 Chief Financial Officer, Senior Vice President

Vivien Wong

60 2016 Executive Vice President - Development

Jeffrey Summer

57 2015 Senior Vice President - Strategy and Performance